Towards effective immunotherapy for lung cancer: simultaneous targeting of tumor-initiating cells and immune pathways in the tumor microenvironment.
Dubinett
Steven
S
Sharma
Sherven
S
D000818:Animals; D017951:Antigen Presentation; D019496:Cancer Vaccines; D002289:Carcinoma, Non-Small-Cell Lung / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D002986:Clinical Trials as Topic; D006801:Humans; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D008175:Lung Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D023461:Myeloid Progenitor Cells / Q000276:immunology; D015398:Signal Transduction; D059016:Tumor Microenvironment
D019496:Cancer Vaccines